During the past decade, Oyama East Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Oyama East Clinic" are "Type 2 Diabetes" (2 trials) and "Diabetes" (1 trials). Many other conditions were trialed in "Oyama East Clinic" in a lesser frequency.

Most popular intervention types in "Oyama East Clinic" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Insulin Degludec" (2 trials) and "Insulin Efsitora Alfa" (2 trials). Other intervention names were less common.

The vast majority of trials in "Oyama East Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Oyama East Clinic". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Oyama East Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oyama East Clinic, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".